Skip to main content

Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal subarachnoid Hemorrhage

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Neurocritical Care

Awarded By

Edge Therapeutics, Inc

Start Date

March 1, 2016

End Date

March 31, 2019
 

Administered By

Neurology, Neurocritical Care

Awarded By

Edge Therapeutics, Inc

Start Date

March 1, 2016

End Date

March 31, 2019